Ardent Health (NYSE:ARDT) Given New $13.50 Price Target at UBS Group

Key Points

• UBS raised its price target on Ardent Health from $13.00 to $13.50 and kept a "buy" rating, implying roughly a 36.7% upside from the prior close.
• Ardent reported an earnings beat (Q EPS $0.28 vs. $0.18 est., revenue $1.60B vs. $1.58B) and set FY2026 guidance of $0.90–$1.27 EPS, versus a sell‑side consensus of $1.11.
• Shares traded at $9.88 with ~727k volume and a $1.41B market cap; the consensus analyst rating is "Hold" with an average target of $14.21 and mixed analyst views (7 Buy / 5 Hold / 2 Sell).

Ardent Health (NYSE:ARDT - Get Free Report) had its target price hoisted by equities research analysts at UBS Group from $13.00 to $13.50 in a note issued to investors on Thursday,Benzinga reports. The firm currently has a "buy" rating on the stock. UBS Group's price objective suggests a potential upside of 36.71% from the stock's previous close.

A number of other equities analysts have also recently issued reports on ARDT. Zacks Research raised Ardent Health from a "strong sell" rating to a "hold" rating in a report on Wednesday, March 25th. Royal Bank Of Canada cut their price target on Ardent Health from $14.00 to $13.00 and set an "outperform" rating on the stock in a research note on Monday, March 9th. JPMorgan Chase & Co. lowered their price objective on Ardent Health from $12.00 to $11.00 and set a "neutral" rating for the company in a research note on Tuesday, January 20th. Finally, Leerink Partners dropped their price objective on shares of Ardent Health from $16.00 to $15.00 and set an "outperform" rating for the company in a report on Friday, March 6th. Seven equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $14.21.

Ardent Health Price Performance

Shares of NYSE:ARDT traded up $0.51 during trading on Thursday, reaching $9.88. 727,156 shares of the company traded hands, compared to its average volume of 399,018. The company's 50 day moving average is $9.26 and its two-hundred day moving average is $9.79. The firm has a market capitalization of $1.41 billion, a PE ratio of 10.39 and a beta of 0.93. The company has a quick ratio of 1.85, a current ratio of 1.97 and a debt-to-equity ratio of 0.64. Ardent Health has a 52 week low of $8.07 and a 52 week high of $15.48.

Ardent Health (NYSE:ARDT - Get Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.28 EPS for the quarter, topping analysts' consensus estimates of $0.18 by $0.10. The company had revenue of $1.60 billion for the quarter, compared to analysts' expectations of $1.58 billion. Ardent Health had a return on equity of 14.01% and a net margin of 2.09%.Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. As a group, sell-side analysts predict that Ardent Health will post 1.11 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in ARDT. Bank of New York Mellon Corp increased its holdings in shares of Ardent Health by 4.2% during the first quarter. Bank of New York Mellon Corp now owns 241,052 shares of the company's stock valued at $2,063,000 after acquiring an additional 9,743 shares in the last quarter. Fifth Third Bancorp bought a new position in shares of Ardent Health in the 1st quarter worth $186,000. Hsbc Holdings PLC acquired a new stake in Ardent Health in the 1st quarter valued at $175,000. R Squared Ltd bought a new stake in Ardent Health during the 1st quarter valued at $120,000. Finally, Abel Hall LLC bought a new stake in Ardent Health during the 1st quarter valued at $87,000.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company's integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.